• Services
    • Antibody Discovery
    • Affinity Maturation
    • Bespoke Phage Display Library Construction
  • Technologies
    • Phage Display
    • Mammalian Display
    • Knotbody Technology
  • About
    • Meet Our Team
    • Careers
    • Partnering
  • Publications
  • News & Events
    • News
    • Events
  • Contact us

PEGS Boston 2018

30 April - 04 May 2018

Boston

Share this article:

  • Twitter
  • LinkedIn
  • Facebook

IONTAS will be attending the Protien Engineering Summit in Boston between the 30th April - 4th May. 

Dr John McCafferty (CEO) and Dr Mike Dyson (CTO) will both be presenting. More details to follow shortly.

People Attending from IONTAS

  • John McCafferty PhD
    -
    Founder / Chief Executive Officer
  • Neil Butt PhD
    -
    Chief Business Officer
  • Mike Dyson PhD
    -
    Chief Technology Officer

Discover the Undiscovered

  • Join our mailing list

About IONTAS

IONTAS is a biotechnology company focused on the development of novel antibody therapeutics. It employs its proven expertise in all key areas of therapeutic antibody discovery and development.

About

  • Our Team
  • Careers

Services

  • Antibody discovery
  • Affinity Maturation
  • Phage Display

Technologies

  • Mammalian Display
  • Phage Display

Misc

  • Publications
  • News
  • Events

Copyright © 2019 IONTAS

Privacy policy

Designed and built by Onespacemedia